← All trials
NCT04420247
Phase 3Interventional
Includes trials conducted after preliminary evidence suggesting effectiveness of the drug has been obtained, and are intended to gather additional information to evaluate the overall benefit-risk relationship of the drug.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Apr 16, 2020
- Primary completion
- May 31, 2020
- Completion date
- Jun 1, 2020
- First posted
- Jun 9, 2020
- Last posted
- Jun 9, 2020
- Enrollment
- 54
- Arms / groups
- 2 / —
- Source
- AACT · ingestion pipeline
Sponsors
- Centro de Estudos e Pesquisa em Emergencias Medicas e Terapia IntensivaLead sponsor
- Centro de Estudos e Pesquisa em Emergencias Medicas e Terapia IntensivaReponsible party - principal investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.